WEE1 inhibition activated the cGAS/STING/TBK1/IRF3 pathway followed by increased IFN-α, IFN-β, CXCL10, and CCL5, which ultimately led to CD8+ T cell recruitment in multiple SCLC in vivo models. The gene discussed is CD8A; the disease is small cell lung carcinoma.